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Abstract. 
 
Many lines of evidence indicate that neoplas-
tic transformation of cells occurs by a multistep process. 
For neoplastic transformation of normal human cells, 
they must be ﬁrst immortalized and then be converted 
into neoplastic cells. It is well known that the immortal-
ization is a critical step for the neoplastic transforma-
tion of cells and that the immortal phenotype is reces-
sive. Thus, we investigated proteins downregulated in 
immortalized cells by two-dimensional gel electro-
 
phoresis. As a result, S100C, a Ca
 
2
 
1
 
-binding protein, 
was dramatically downregulated in immortalized hu-
man ﬁbroblasts compared with their normal counter-
parts. When the cells reached conﬂuence, S100C was 
phosphorylated on threonine 10. Then the phosphory-
lated S100C moved to and accumulated in the nuclei of 
normal cells, whereas in immortalized cells it was not 
phosphorylated and remained in the cytoplasm. Micro-
injection of the anti-S100C antibody into normal con-
ﬂuent quiescent cells induced DNA synthesis. Fur-
thermore, when exogenous S100C was compelled to 
localize in the nuclei of HeLa cells, their DNA synthesis 
was remarkably inhibited with increase in cyclin-depen-
dent kinase inhibitors such as p16
 
Ink4a
 
 and p21
 
Waf1
 
. 
These data indicate the possible involvement of nuclear 
S100C in the contact inhibition of cell growth.
Key words: immortalization of human cells • S100C 
protein • actin ﬁlaments • nuclear import • cell den-
sity–dependent growth arrest
 
Introduction
 
Many lines of evidence indicate that neoplastic transfor-
mation of cells occurs by a multistep process, which is
clearly determined by the successive stages of aging, im-
mortalization, and neoplastic transformation (Namba et al.,
1996; Hayflick, 1997). It is well known that normal human
diploid cells are extremely refractory to in vitro neoplastic
transformation, because they cannot be easily immor-
talized. Once they are immortalized, they can easily un-
dergo neoplastic transformation by treatment with carcino-
genic agents, including chemicals, radiation, and oncogenes
(Rhim et al., 1990; Namba et al., 1996). These facts indi-
cate that cellular immortalization is an important early
step of human carcinogenesis. However, the molecular
mechanism responsible for cellular immortalization is still
poorly understood.
Two-dimensional (2-D)
 
1
 
 PAGE is one of the powerful
techniques for analyzing protein dynamics under various
physiological conditions of cells. In this study, we used the
2-D PAGE technique to investigate the protein dynamics
in normal and immortalized human fibroblasts in order to
understand the mechanisms of cellular immortalization.
We found that S100C (S100A11, calgizzarin: pI 6.2, molec-
ular mass 11 kD) was dramatically downregulated in im-
mortalized human fibroblasts as compared with their nor-
mal counterparts.
S100C is a member of EF-hand type Ca
 
2
 
1
 
-binding pro-
tein of the S100 family and was first identified in chicken
gizzard smooth muscle and has also been detected in sev-
eral mammalian species and tissues (Watanabe et al., 1991;
Tanaka et al., 1995; Schnekess and Walsh, 1997). It has
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S
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been suggested that the S100 family, including S100C,
plays important roles in cell cycle regulation, differentia-
tion, growth, and metabolic control (Allen et al., 1996;
Marti et al., 1996; Scotto et al., 1998). Many studies have
been carried out to determine the functions of S100C in
vivo and in vitro; however, little is known about its precise
intracellular functions. The purpose of this study was to in-
vestigate the biological functions of S100C in normal hu-
man fibroblasts and their immortalized cells.
 
Materials and Methods
 
Cell Culture, 
 
32
 
P Labeling, Bromodeoxyuridine (BrdU) 
Labeling, and [
 
3
 
H]Thymidine Incorporation
 
Normal human fibroblast strains (KMS-6, OUMS-36, and OUMS-24) and
their immortalized cell lines (KMST-6, SUSM-1, and OUMS-24F) were
cultured in a 5% CO
 
2
 
 incubator at 37
 
8
 
C. MEM (Nissui) supplemented
with 10% FBS (Intergen Co.) was used. Characteristics of these cell lines
have been described elsewhere (Namba et al., 1985, 1988; Bai et al., 1993).
 
32
 
P labeling of cells was performed as described previously (Kondo et al.,
1995). In brief, cells were incubated in a phosphate-free medium for 2 h
and then labeled with [
 
32
 
P]orthophosphate at a dose of 100 mCi/ml (ICN)
at 37
 
8
 
C for 6 h. For phosphorylation of recombinant S100C in a cell-free
system, confluent normal KMS-6 cell pellets were lysed in 500 
 
m
 
l of deter-
gent disruption buffer (0.5% NP-40, 2.5 mM DTT, 15% glycerol, 1 mM
NaF, 0.1 mM Na
 
3
 
VO
 
4
 
, 135 mM KCl, 100 
 
m
 
M CaCl
 
2
 
, 1 
 
m
 
g/ml leupeptin, 1
 
m
 
g/ml aprotinin, 50 mM Tris-HCl, pH 7.4). Supernatants were separated
by a 20-min centrifugation at 15,000 rpm, and protein contents were ad-
justed to 1 mg/ml. Purified recombinant glutathione 
 
S
 
-transferase (GST)-
S100C (1 
 
m
 
g) and [
 
g
 
-
 
32
 
P]ATP (1 
 
m
 
Ci) were added to the supernatants and
incubated for 25 min at 25
 
8
 
C. 
 
32
 
P-labeled GST-S100C in cell lysates was
obtained by glutathione-agarose affinity chromatography. 
 
32
 
P-labeled
S100C was cut off by treatment of the 
 
32
 
P-labeled GST-S100C with bovine
thrombin and then subjected to the SDS-PAGE. DNA synthesis was as-
sessed by BrdU (Sigma) (Dover and Patel, 1994) or [
 
3
 
H]thymidine up-
take. Detection of the BrdU was carried out using mouse anti-BrdU anti-
body (Neomarkers) as the primary antibody and FITC-conjugated goat
anti–mouse IgG antibody (Sigma) as the secondary antibody. To assay
[
 
3
 
H]thymidine incorporation, trypsinized cells were plated in 24-well
plates at a density of 5 
 
3
 
 10
 
4
 
 cells/ml and cultured overnight at 37
 
8
 
C
in MEM supplemented with 10% tetracycline system-approved FBS
(CLONTECH Laboratories, Inc.) and doxycycline (1 
 
m
 
g/ml). Then, the
medium was replaced with the fresh medium containing no doxycycline,
and the cells were further incubated for 3–12 h. Tritiated thymidine (1
 
m
 
Ci/ml; ART) was added to the cultures 3 h before cell harvest.
 
Expression Vectors
 
The procaryote expression plasmid pGEX-2T-S100C was constructed to
express a GST-S100C fusion protein by inserting the cDNA of human
S100C into the pGEX-2T vector (Naka et al., 1994). To delete the phos-
phorylation site of S100C protein, three mutant expression plasmids
(pGEX-2T 8-10 A/T S100C, 8 A/T S100C, and 10 A/T S100C) were con-
structed to express various S100C protein homologues (8-10 A/T, 8 A/T,
and 10 A/T). A total of 10 primers (CCAGCCCTGCAGAGGCTGA-
GCGGTGC; T8-10-A F, CTCCAGCCCTGCAGAGACTG; T8-A F, CCA-
GCCCTACAGAGGCTGAGCGGTGC; T10-A F, TATAGCATGGC-
CTTTGCAGGG; GST F as 5
 
9
 
-primers; and GCACCGCTCAGCCT-
CTGCAGGGCTGG; T8-10-A R, CAGTCTCTGCAGGGCTGGAG;
T8-A R, GCACCGCTCAGCCTCTGTAGGGCTGG; T10-A R, ATT-
CATGAAGCTTAGGAACTC; HindR as 3
 
9
 
-downstream primers) were
used. Three sets of PCR products (T8-10-A F/HindR and T8-10-A R/GST
F; T8-A F/HindR and T8-A R/GST F; T10-A F/HindR and T10-A R/GST
F) were synthesized on a pGEX-2T-S100C template by first PCR, and
they were then religated by second PCR using the 5
 
9
 
-primer GST F and
the 3
 
9
 
-downstream primer HindR. These fragments were inserted into the
BamH1/HindIII site of pGEX-2T-S100C plasmid. Nucleotide sequences
of these mutant S100C expression vectors were confirmed by direct se-
quencing. The human S100C expression plasmid pTracer-EF-A-S100C
was constructed to overexpress S100C in cells. A 306-bp NotI-NotI frag-
ment was obtained by PCR of pGEX-2T-S100C vector using a 5
 
9
 
-primer
 
(GCGGCCGCATGGCAAAAATCTCCAGC) and a 3
 
9
 
-downstream
primer (GCGGCCGCTCAGGTCCGCTTCTGGGA). The fragment
containing the open reading frame of the human 
 
S100C
 
 gene was ligated
to the NotI site of the eukaryote expression vector pTracer-EF-A (Invi-
trogen). The pTRE S100C–nuclear localization signal (NLS) vector was
constructed to specifically localize S100C-NLS fusion protein in the nu-
cleus. Human S100C cDNA linked to simian virus 40 large T antigen NLS
(PKKKRKV) cDNA was obtained by PCR of pGEX-2T-S100C vector
using a 5
 
9
 
-primer (CTCAGCTCCAACATGGCAAA) and a 3
 
9
 
-down-
stream primer (TTATACCTTTCTCTTCTTTTTTGGGGTCCGCTTC-
TGGGAAGGGA). S100C-NLS cDNA was subcloned into the pGEM-T
easy cloning vector (Promega) and restricted by EcoRI. The fragment was
ligated to EcoRI site of the pTRE cloning vector. The pTRE S100C vec-
tor was also constructed. The EcoRI restricted fragments of the pGEM-T
vector containing S100C cDNA was ligated to a pTRE cloning vector. Nu-
cleotide sequences of these S100C expression vectors were confirmed by
DNA sequencing.
 
Transfection
 
Tet-off HeLa cell line (Clontech) was doubly transfected with pTRE
S100C or pTRE S100C-NLS and pSV2-Hyg selection vector carrying hy-
gromycin B resistance gene (ratio, 10:1) by lipofection using Lipo-
fectamine (GIBCO BRL) according to the manufacturer’s instructions.
After 48 h, stably transfected clones were selected by hygromycin B (200
 
m
 
g/ml) in MEM supplemented with 10% Tet system approved FBS (Clon-
tech) and doxycycline (1 
 
m
 
g/ml).
 
2-D Gel Electrophoresis
 
Protein sampling and isoelectric focusing separation with immobilized pH
gradient (pH, 4.0–7.0) gels (IPG; Amersham Pharmacia Biotech) were
performed as described previously (Kondo et al., 1998a). After equilibra-
tion with SDS, the IPG gels were placed directly onto 15% tricine SDS-
polyacrylamide slab gels and run with a vertical electrophoresis system
(Nihon Eido). Owing to the nature of this system, we used two types of
running buffer for electrophoresis, i.e., a top running buffer (0.1 M tricine,
0.1% SDS, 0.1 M Tris, pH 8.2) as a cathode and a bottom running buffer
(0.2 M Tris, pH 8.9) as an anode.
 
Protein Sequencing
 
Coomassie brilliant blue (CBB)-stained protein on a polyvinylidene diflu-
oride filter (PVDF) membrane was digested with 1 pmol of lysyl endopep-
tidase (
 
Achromobacter protease
 
 I; WAKO). Some peptide fragments
eluted from the PVDF membrane were separated on a C18 column
(YMC-pack ODS-A, 150 mm 
 
3
 
 6.0 mm ID; Amersham Pharmacia Bio-
tech) by HPLC, with monitoring of their absorbance at 210 nm. The sepa-
rated peptides were subjected to NH
 
2
 
-terminal sequencing on a Model
491 peptide sequencer (Applied Biosystems). For NH
 
2
 
-terminal sequenc-
ing of phosphopeptide, the spot of phosphopeptide on a TLC plate was
scraped off and extracted with electrophoresis buffer (formic acid/acetic
acid/double-distilled water (DDW), 1:3:16). After drying the extract, the
dried sample was moistened by SDS sample buffer, subjected to tricine
SDS-PAGE, and blotted onto a PVDF membrane. The peptide band was
cut off from the CBB-stained PVDF membrane, and the peptide sequence
was analyzed by the peptide sequencer.
 
Antibody to Recombinant Human S100C Protein
 
Escherichia coli
 
 (
 
E. coli
 
 NM 522) cells were transformed by the procary-
ote expression vector pGEX-2T-S100C. Purification of the GST-S100C
fusion protein in transformed cell extracts was performed by glutathione-
agarose affinity chromatography using a Sephadex 4B column (Amer-
sham Pharmacia Biotech). After dialysis of the GST-S100C fraction with a
dialysis buffer (150 mM NaCl, 1.5 mM KCl, 20 mM Tris, pH 7.4), bovine
thrombin was added to the GST-S100C solution at a concentration of
1:200 (wt/wt). The mixture was incubated at 37
 
8
 
C for 60 min to complete
the proteolysis reaction, and then S100C protein was isolated from the
protein mixture by chromatography with a Sephadex 4B column. For
preparation of anti–human S100C antibody, rabbits were immunized
three times for 2 mo with the human recombinant S100C (each at 1 mg
per animal). Immune serum was collected from each rabbit and the IgG
fraction was isolated by salting-out. We confirmed that anti-S100C anti-
body reacted specifically with human S100C (11 kD) on Western blot. 
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Immunocytochemistry
 
To visualize S100C and actin filaments simultaneously, cells were treated
with rabbit anti-S100C antibody at 37
 
8
 
C for 1 h and treated with BODIPY
558/568–conjugated phalloidin (a specific probe for actin filaments; Mo-
lecular Probes, Inc.) under the same conditions reported previously (Sak-
aguchi et al., 1998, 1999; Kondo et al., 1998b). Then, cells were treated at
37
 
8
 
C for 1 h with a secondary antibody and FITC-conjugated goat anti-
rabbit IgG antibody (Sigma).
 
Immunostaining of Exogenously Added S100C
 
Total cell extracts were prepared by homogenizing normal and immortal-
ized cells at various stages in a homogenizing buffer (10 mM KCl, 3 mM
ATP, 5 mM MgCl
 
2
 
, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, and 200 
 
m
 
g/ml
phenylmethanesulfonyl fluoride, 10 mM Hepes, pH 7.0). Confluent nor-
mal and immortalized cells on coverslips were permeabilized with digito-
nin (Mishra and Parnaik, 1995; Yokoya et al., 1999) and then incubated
with normal or immortalized cell extracts that were treated with or not
treated with alkaline phosphatase from 
 
Escherichia coli
 
 (WAKO) at 37
 
8
 
C
for 15 min. Thereafter, the cells were immunostained for S100C as de-
scribed above.
 
Immunoprecipitation and Immunoblotting
 
Total cell lysates were prepared from normal and immortalized cells at
various stages with a cell lysis buffer (300 mM NaCl, 1% Triton X-100, 1 mM
CaCl
 
2
 
, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, and 200 
 
m
 
g/ml phenyl-
methanesulfonyl fluoride, 10 mM Tris, pH 7.3). Subfractionation of the to-
tal cell lysates was carried out basically as described previously (Lindeman
et al., 1997). In brief, the total cell lysates, soluble, and nuclear fractions
were cleared by treatment with excess of protein A–Sepharose (Sigma).
Cleared cell samples were incubated with rabbit anti-S100C antibody at
4
 
8
 
C for 60 min followed by protein A, and the immunoprecipitates were
resolved on tricine SDS-PAGE and transferred onto nitrocellulose mem-
branes (Amersham Pharmacia Biotech). Immunoblotting of the mem-
branes was performed as reported previously (Sakaguchi et al., 1999) us-
ing rabbit anti-S100C antibody or rabbit anti-actin antibody followed by
HRP-conjugated goat anti–rabbit IgG antibody (MBL). Then, S100C and
actin were detected by the enhanced chemiluminescence system (Amer-
sham Pharmacia Biotech). Native polyacrylamide gel electrophoretic
analysis was performed as reported previously (Tom et al., 1996). In brief,
the total cell lysates were resolved in 4% native polyacrylamide gels at 4
 
8
 
C
and then immunoblotted with rabbit anti-S100C antibody as described
above.
 
Cosedimentation Assay
 
To examine binding of S100C to purified actin filaments, a simple high-
speed cosedimentation assay was performed as described previously
(González et al., 1998). Purified monomeric actin (G-actin, 10 
 
m
 
M; Sigma)
was incubated with recombinant GST-S100C (10 
 
m
 
M) or GST (10 
 
m
 
M) in
an actin polymerization buffer (2 mM MgCl
 
2
 
, 100 mM KCl, 0.1 mM ATP,
10 mM Hepes, pH 7.3) containing various concentrations of Ca
 
2
 
1
 
 at room
temperature for 60 min to complete actin polymerization. Association of
recombinant S100C with polymerized actin filaments was determined by a
sedimentation assay with ultracentrifugation at 126,000 
 
g
 
 for 20 min in a
Beckman Airfuge. Equal volumes of the pellet and supernatant from each
reaction mixture were subjected to SDS-PAGE. The amounts of GST-
S100C and actin were then quantified by densitometry of the stained gels.
 
DNase I Affinity Chromatography
 
Affi-Gel 10 (Bio-Rad) coupled with DNase I, which specifically binds to
G-actin, was used to examine the interaction of G-actin with GST-S100C.
G-Actin (10 
 
m
 
M)-bound DNase I affinity beads and various concentra-
tions of GST-S100C (1–100 
 
m
 
M) in a hypoionic strength buffer (0.1 mM
ATP, 10 mM Hepes, pH 7.3) were incubated for 2 h at room temperature
in the presence of 1 mM Ca
 
2
 
1
 
. After the incubation, the beads were
washed three times with the same buffer, resuspended in the electro-
phoresis sample buffer, and analyzed by SDS-PAGE.
 
2-D Separation of S100C Phosphopeptides
 
32
 
P-labeled phosphopeptide mapping was performed essentially as de-
scribed previously, with a minor modification (Fackler et al., 1990). In
brief, bands containing 
 
32
 
P-labeled cellular S100C or recombinant S100C
were excised from the dried SDS-polyacrylamide gel, rehydrated, and di-
gested in 50 mM NH
 
4
 
HCO
 
3
 
 buffer, pH 8.3, containing lysyl endopeptidase
for 16 h at 37
 
8
 
C. The ratio (mol/mol) of lysyl endopeptidase and S100C
was 1:100. After centrifugation of the excised gel suspension, the super-
natant was collected and lyophilized. The lyophilized sample was dis-
solved in 1 ml DDW and relyophilized. This process was repeated five
times to completely remove NH
 
4
 
HCO
 
3
 
. The finally lyophilized samples
were dissolved in 5 
 
m
 
l of electrophoresis buffer (formic acid/acetic acid/
DDW, 1:3:16) and applied to thin layer plates (Amersham Pharmacia Bio-
tech). Electrophoresis was carried out in the first dimension at 1,000 V for
30 min with cooling at 4
 
8
 
C. After drying, the plate was chromatographed
for 3–4 h in the second dimension in n-butanol/pyridine/acetic acid/DDW
(6.5:5:1:4) until the leading edge of the solvent had reached 1–2 cm from
the top.
 
Phosphoamino Acid Analysis
 
Lysyl endopeptidase digests of 
 
32
 
P-labeled intracellular S100C and recom-
binant S100C were incubated in 100 
 
m
 
l of 6 N HCl at 105
 
8
 
C for 60 min as
described previously (Fackler et al., 1990). The samples were concen-
trated by a Speed Vac concentrator and dissolved in 5 
 
m
 
l of DDW con-
taining standards (each 1 mg/ml of cold phosphoserine, phosphothreo-
nine, and phosphotyrosine). Electrophoresis was carried out at 1,000 V for
50 min with cooling at 4
 
8
 
C using a pyridine/acetic acid/DDW (1:10:189)
electrophoresis buffer. After drying the plates, the standards were identi-
fied with ninhydrin spray (Sigma). Then, 
 
32
 
P-labeled phosphoamino acids
were visualized by autoradiography.
 
Microinjection of S100C Expression Vector or Rabbit 
Anti–human S100C Antibody
 
The plasmid pTracer-EF-A-S100C was microinjected at a dose of 500 cop-
ies per nucleus into immortalized cells grown on coverslips. After 24 h,
cells were fixed and observed under a fluorescence microscope. NBD flu-
oride (Molecular Probe), an amine reactive fluorescent probe, was conju-
gated with purified recombinant S100C according to the manufacturer’s
recommended protocol. The S100C-NBD fluoride (5 mg/ml) was microin-
jected into the cytoplasm of normal semiconfluent fibroblasts at a dose of
50 fl per cell, and the injected cells were incubated at 37
 
8
 
C for 2 h and then
observed under a fluorescent microscope. For microinjection of rabbit
anti-S100C antibody, normal cells were plated on coverslips. After reach-
ing confluence, the cells were further maintained for 2 wk with three
changes of the medium. After confirmation that the cells did not incorpo-
rate any BrdU, rabbit anti-S100C antibody (5 mg/ml) was microinjected
into the cytoplasm at a dose of 50 fl per cell, and the injected cells were in-
cubated at 37
 
8
 
C for 24 h. Localization of rabbit anti-S100C antibody in the
injected cells was detected with TRITC-conjugated goat anti–rabbit IgG
antibody (Sigma). Then, DNA synthesis in the injected cells was assessed
by BrdU staining.
 
Results
 
S100C in Human Fibroblasts
 
In analysis using semiconfluent cells by 2-D gel electro-
phoresis, several hundred proteins were detected per sil-
ver-stained gel, and numerous differences in the protein
expression levels were observed between normal and im-
mortalized cells (Fig. 1 a). We noticed a spot of low–
molecular weight protein that was downregulated in im-
mortalized KMST-6 cells as compared with their normal
counterparts (Fig. 1 a, arrows). The isoelectric point and
molecular mass of the protein were 6.2 and 11 kD, respec-
tively. The amino acid sequence of the protein was then
determined. Nine peaks were obtained by HPLC separa-
tion of the lysyl endopeptidase digests, and four (Nos. 2, 3,
8, and 9) of them were sequenced (Fig. 1 b). At the top of
Fig. 1 c, the sequences of the four peptides (Nos. 2, 3, 8,
and 9) are shown. These sequences completely correspond
to the underlined sequences of the full-length human 
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S100C (bottom of Fig. 1 c). As a result, the amino acid se-
quences of the four peptides were completely coincident
with the partial sequence of human S100C protein (Fig. 1
c). Thus, we concluded that this protein was the human
S100C protein.
To determine the biological functions of S100C, we built
up a monospecific polyclonal antibody to human S100C
(Fig. 1 d). Western blot analysis with the antibody showed
that expression of the S100C protein was lower in immor-
talized fibroblast cell lines (KMST-6, SUSM-1, OUMS-
24F) than in normal human fibroblast strains (KMS-6,
OUMS-36, OUMS-24) at semiconfluence (Fig. 1 e). In ad-
dition, we found that the expression of the protein in-
creased in parallel to cell density in both normal and im-
mortalized cells (Fig. 1 f).
 
Localization of S100C in Cells
 
We next examined the subcellular distribution of S100C in
normal and immortalized cells at low and high cell densi-
ties using the rabbit anti-S100C antibody. Immunoblot
analyses showed that S100C was predominantly present in
the soluble fractions from normal and immortalized cells
at semiconfluence (Fig. 2 a). Interestingly, S100C accumu-
lated in the nuclei of normal cells when they reached con-
fluence, whereas it remained in the cytoplasm of immor-
talized cells even after confluence (Fig. 2 a). No difference
in the cDNA sequence of S100C was observed between
normal KMS-6 and immortalized KMST-6 cells (data not
shown), indicating that different localization of S100C in
normal and immortalized cells at confluence was not due
to the 
 
S100C
 
 gene mutation.
Although it has been proposed that S100C can associate
with actin cytoskeletal protein in vitro (Naka et al., 1994),
it is still unclear whether the association actually occurred in
human fibroblasts. For this point, the interaction between
S100C and actin filaments in cells was further evaluated by
GST fusion protein binding and immunoprecipitation as-
says. By loading extracts of normal and immortalized cells
onto a column filled with glutathione beads coupled with
GST-S100C fusion protein (Fig. 2 b, top right) or GST
alone (Fig. 2 b, top left), we detected a protein with a mo-
Figure 1. Identification of
S100C in human fibroblasts.
(a) 2-D gels of silver-stained
proteins from normal human
fibroblasts  (KMS-6, left
panel) and their immortalized
counterparts (KMST-6, right
panel). Arrows show a pro-
tein with a molecular mass of
11 kD and isoelectric point
of 6.2. (b) Peptide mapping
of this protein was performed
by lysyl endopeptidase diges-
tion and separation of cleav-
age products on reverse-
phase HPLC using a C18
column. Nine major peptides
were separated. (c) Amino
acid sequences of four (Nos.
2, 3, 8, and 9) out of the nine
peptides were determined.
Underlined parts of full
amino acid sequence of hu-
man S100C show consensus
sequences of the four pep-
tides. (d) Monospecificity of
rabbit anti–human S100C an-
tibody built up in this study
was confirmed by Western
blot analysis. (Left lanes)
CBB staining. (Right lanes)
Western blot of S100C: lane
1, 1 mg of recombinant hu-
man S100C; lanes 2 and 3, 30
and 60 mg of proteins from
normal cells. (e) Comparison
of S100C (upper) or tubulin
(control, lower) expression levels in three normal (KMS-6, OUMS-36, OUMS-24) and three immortalized (KMST-6, SUSM-1, OUMS-
24F) cells at low cell density by Western blot analysis using rabbit anti-S100C or anti-tubulin antibody. (f) After cells reached conflu-
ence, changes in amounts of S100C were assessed by Western blotting. (Left panel) Three normal cell strains (KMS-6, OUMS-36,
OUMS-24). (Right panel) Three immortalized cell lines (KMST-6, SUSM-1, OUMS-24F): lane 1, semiconfluent stage; lanes 2–4, 24, 48,
and 72 h after reaching confluence, respectively. 
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lecular mass of 42 kD in eluates from the GST-S100C col-
umn (Fig. 2 b, top right) but not from the control GST col-
umn (Fig. 2 b, top left). Western blot analysis showed that
the GST-S100C binding protein (42 kD) was actin (Fig. 2
b, bottom right). When whole cell lysates from normal and
immortalized cells at semiconfluence and confluence were
immunoprecipitated with rabbit anti-S100C antibody, ac-
tin was coprecipitated with S100C in these lysates (Fig. 2
c). In contrast, neither S100C nor actin was detected in im-
munoprecipitates prepared with preimmune serum (data
not shown). Actin bound to S100C was detected in the sol-
uble fractions from both normal and immortalized cells at
semiconfluent and confluent stages but not in the nuclear
fractions (Fig. 2 d). These results clearly show that S100C
associates with actin filaments in the cytoplasm but not in
the nucleus of both types of cells independently of cell
density.
Immunofluorescence staining of normal and immortal-
ized semiconfluent cells showed that S100C was distrib-
uted in the cytoplasm (Fig. 3, a and b). At confluence, in-
tranuclear distribution of S100C was observed in normal
cells but not in immortalized cells (Fig. 3, c and d). Prein-
cubation of anti-S100C antibody with the purified recom-
binant S100C protein diminished the immunostaining of
S100C (Fig. 3, a# and c#). In addition, the cells were not
stained with preimmune serum, and this distribution pat-
tern was reproduced with different fixations, such as meth-
anol and acetone fixations (data not shown). These results
indicated that the S100C immunostain pattern was spe-
cific.
Immunofluorescence staining also demonstrated that
S100C was colocalized with actin stress fibers (Fig. 3, e, f,
e-a
 
9
 
, and f-b
 
9
 
). In addition, a clear colocalization pattern of
S100C with actin filaments was visualized at the leading
edge, namely filopodia (Fig. 3, g and h, arrows) and lamel-
lipodia (Fig. 3, i and j, arrows) of cells. The leading edge is
known as a region where actin filaments are involved in
the formation of pseudopodia such as filopodia and lamel-
lipodia (Burridge et al., 1988; Bretscher, 1991). These find-
ings strongly suggest that S100C interacts with actin fila-
ments.
To determine the physiological significance of the inter-
action between S100C and actin filaments, we microin-
jected the S100C expression vector pTracer-EF-A-S100C
into the nuclei of immortalized cells that expressed only a
small amount of endogenous S100C at a low cell density.
After 24 h, we observed drastic morphological changes in
the S100C-injected cells. These changes were accompa-
nied by the formation of cell protrusions (Fig. 3 k). No
similar changes were observed in the cells injected with an
empty vector as a negative control (Fig. 3 l). Immunofluo-
rescence staining of actin showed remarkable accumula-
tion of actin filaments in pseudopodia of the cells injected
with the S100C expression vector (Fig. 3, m and n, arrows).
We further confirmed that these changes were not due to
toxic effects of overexpressed S100C, because these cells
were viable as judged by the results of a trypan blue exclu-
sion test (data not shown). These results indicated that
S100C could control actin organization and have a signifi-
cant influence on cell morphology.
Figure 2. Association of
S100C with actin filaments.
(a) Subcellular distribution
of S100C and actin filaments
in soluble and nuclear frac-
tions was determined by
Western blotting. (b) Sil-
ver staining of GST-S100C
(right) or GST (left) binding
proteins in normal (lane 1)
and immortalized cells (lane
2). Arrowhead indicates a
42-kD protein that was
coprecipitated with GST-
S100C, but not GST alone.
This protein was identified as
actin by Western blotting us-
ing rabbit anti-actin antibody
(b, bottom). (c and d) Asso-
ciation of S100C with actin
filaments in normal and im-
mortalized cells by immuno-
precipitation assay. Whole
cell lysates (c), and soluble
(S) and nuclear (N) fractions
(d) from normal and immor-
talized cells at semiconfluent
and confluent stages were
immunoprecipitated with
rabbit anti-S100C antibody. These immunoprecipitates were separated on 15% tricine SDS-PAGE and transferred to nitrocellulose
membranes and subjected to the reaction with rabbit anti-actin antibody (c, middle and bottom; d, bottom) and rabbit anti-S100C anti-
body (c, top; d, top). Total amounts of actin in whole cell lysates were determined by Western blot analysis using rabbit anti-actin anti-
body (c, bottom). 
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Interaction of S100C with Actin Filaments In Vitro and 
In Vivo
 
By coimmunoprecipitation and affinity chromatography,
we demonstrated that endogenous S100C actually binds to
actin. However, it is not clear what type of actin, for ex-
ample, G-actin (monomeric actin) or F-actin (actin fila-
ments), associates with S100C. In addition, it remains to be
determined whether interaction of S100C with actin is not
direct but mediated via an unidentified linker protein(s).
Thus, we further investigated the in vitro interaction
between S100C and actin filaments by cosedimentation
assay.
As shown in Fig. 4 a, when affinity-purified GST-S100C
was added to G-actin before its polymerization reaction,
GST-S100C was directly incorporated into actin filaments
assembled in a Ca
 
2
 
1
 
-dependent manner, whereas S100C-
GST failed to bind to actin filaments in the absence of
Ca
 
2
 
1
 
. GST alone was never incorporated into actin fila-
ments. Interaction of S100C-GST with G-actin was eval-
uated by a coprecipitation assay using G-actin–bound
DNase I affinity beads in the presence of 1 mM Ca
 
2
 
1
 
. Fig.
4 b shows that G-actin alone did not associate with GST-
S100C even though excessive amounts of S100C-GST
were added to the mixture. If S100C and DNase I have the
same or overlapping binding sites on the actin monomer,
binding of S100C to G-actin may not be observed. This
possibility remains to be determined. To decide the molar
ratio of an S100C–actin filaments complex, densitometric
analysis of the in vitro–assembled complex was done, and
the results are shown in Fig. 4 c. The amount of GST-
S100C that bound to actin filaments increased in parallel
with the amount of GST-S100C added, and the mol:mol
ratio of GST-S100C and actin filaments was 
 
z
 
1:1. To fur-
ther examine the interaction of S100C with actin filaments
in cells, recombinant S100C labeled with a fluorescent
probe was microinjected into the cytoplasm of normal
semiconfluent fibroblasts. After 2 h of incubation, the in-
jected exogenous S100C coexisted with actin filaments in a
meshwork structure in the cytoplasm (Fig. 4 d). These re-
sults coincide well with the immunofluorescent staining
patterns of the endogenous S100C in cells (Fig. 3, e and
e-a
 
9
 
). Thus, we concluded that S100C directly interacted
with actin filaments in a Ca
 
2
 
1
 
-dependent manner.
 
Figure 3.
 
Subcellular localization of S100C in normal KMS-6 and
immortalized KMST-6 cells at semiconfluent and confluent
stages. S100C was visualized by immunofluorescence staining.
(a–d) Normal (a and c) and immortalized cells (b and d) were
stained at semiconfluence (a and b) or at confluence (c and d).
S100C was detected in the nuclei of normal cells at confluence.
Preincubation of anti-S100C antibody with recombinant S100C
diminished the immunostaining (a# and c#). (e–j) Double immu-
nofluorescence stainings were performed in normal cells with
rabbit anti-S100C antibody (e, e-a
 
9
 
, g, and i) and BODIPY 558/
568–conjugated phalloidin (f, f-b
 
9
 
, h, and j). S100C and actin were
identified by fluorescence-labeled second antibodies, FITC
(green) for S100C, and BODIPY 558/568 (red) for actin, respec-
tively. In interphase cells, the interaction of S100C with actin fila-
ments (e and f) was visualized in cytoplasmic domains (enlarged
view of e and f, e-a
 
9
 
, and f-b
 
9
 
). After allowing the cells to attach
to and spread on coverslips for 1 h, S100C (g and i) and actin fila-
ments (h and j) were stained in the cells. Arrows show colocaliza-
tion of S100C and actin filaments at the leading edges of filopo-
dia (g and h) and lamellipodia (i and j). (k–n) Immortalized cells
at semiconfluence were microinjected with the S100C expression
vector (k, m, and n, pTracer-S100C cDNA) or empty vector (l,
pTracer). S100C-expressing (k and m) and -nonexpressing cells
(l) were detected by a GFP marker (green) inserted in pTracer,
and actin in the cells injected with pTracer-S100C (m) was visual-
ized by BODIPY 558/568–conjugated phalloidin staining (n,
red). S100C-expressing cells display a drastic morphological
change accompanied by the formation of cell protrusions (k and
m) with remarkable accumulation of actin filaments (n, arrows).
Bars: 20 
 
mm (b, d, f, l, and m); 5 mm (f-b9); 10 mm (j).Sakaguchi et al. S100C and Cell Growth 1199
Movement of S100C into Nuclei of Normal Cells
at Confluence
The nuclear localization of S100C in permeabilized nor-
mal cells was not affected by the addition of extracts of im-
mortalized cells at semiconfluent (Fig. 5 a, panel I) and
confluent stages (Fig. 5 a, panel II). When immortalized
confluent cells were permeabilized with digitonin and in-
cubated with the extracts of normal semiconfluent cells,
S100C still remained in the cytoplasm (Fig. 5 a, panel III).
However, S100C in immortalized confluent cells moved
into the nuclei when the cells were permeabilized and in-
cubated with the extracts of normal confluent cells (Fig. 5
a, panel IV). These results indicate that S100C can move
from the cytoplasm into the nucleus of normal cells at con-
fluence, but that this motility of the protein is lost in im-
mortalized cells. In other words, cytoplasmic localization
of S100C in immortalized cells does not depend on the nu-
clear exclusion capacity of S100C in the cells.
Interestingly, S100C was phosphorylated only in normal
confluent cells (Fig. 5 b). This phosphorylation was mark-
edly reduced by treatment of the cell extracts with alkaline
phosphatase (an E. coli enzyme, 4 U) at 378C for 1 h (Fig.
5 c). In addition, electrophoretic separation in the native
condition followed by immunoblotting with S100C anti-
body revealed three (large, middle, and small) protein
bands in normal semiconfluent cells as well as immortal-
ized cells at semiconfluent and confluent stages (Fig. 5 d).
However, the middle band was lost in normal confluent
cells (Fig. 5 d). The middle band reappeared when normal
confluent cell extracts were treated with alkaline phos-
phatase. When the normal confluent cell extracts were
added to permeabilized immortalized cells, S100C moved
Figure 4. Ca21-dependent in-
teraction of S100C with actin
filaments. (a) In vitro analy-
sis of complex formation be-
tween S100C and actin fila-
ments. Recombinant S100C
was produced as GST fusion
protein in E. coli and purified
with glutathione-Sepharose
beads. Lanes 1–6 show the
increasing concentrations of
Ca21 (lane 1, 0 M; lane 2,
1027 M; lane 3, 1026 M; lane
4, 1025 M; lane 5, 1024 M;
lane 6, 1023 M). Actin fila-
ments (10 mM) were mixed
with GST-S100C (10 mM) or
GST (10 mM), incubated, and
ultracentrifuged. The super-
natants and pellets were sub-
jected to SDS-PAGE and an-
alyzed by silver staining.
The amount of GST-S100C
bound to actin filaments in-
creased in parallel with Ca21
concentration. (b) In vitro
analysis of interaction be-
tween S100C and G-actin.
Various concentrations of
GST-S100C (lane 1, 1 mM;
lane 2, 5 mM; lane 3, 10 mM;
lane 4, 25 mM; lane 5, 50
mM; lane 6, 100 mM) were
mixed with DNase I affinity
beads coupled with G-actin
(10  mM) in the presence of 1
mM Ca21 (the best concen-
tration of Ca21 determined in a) and incubated. After centrifugation, the bead-bound fractions and supernatants (unbound fractions)
were analyzed by SDS-PAGE followed by silver staining. S100C did not associate with G-actin. (c) Cosedimentation assay of GST-
S100C with actin filaments. Actin filaments (20 mM) were mixed with increasing concentrations of GST-S100C (M, maker; lane 1, 0 mM;
lane 2, 10 mM; lane 3, 20 mM; lane 4, 30 mM; lane 5, 40 mM) in the presence of 1 mM Ca21. After cosedimentation, the pellets were sub-
jected to SDS-PAGE, and each band intensity was densitometrically quantified. The results show that the binding ratio (mol:mol) of
GST-S100C and actin filaments is z1:1. (d) Subcellular localization of exogenous S100C in normal semiconfluent KMS-6 cells. Recom-
binant S100C labeled with a fluorescent probe was microinjected into the cytoplasm of KMS-6 cells. Localization of exogenous S100C
was evaluated by observation under a fluorescent microscope. The exogenous S100C (a and a9) was colocalized with actin filaments (b
and b9) in the cytoplasm. a9 and b9 show enlarged views of a and b, respectively. Bars: 20 mm (b); 5 mm (b9).The Journal of Cell Biology, Volume 149, 2000 1200
into the nucleus, whereas the protein remained in the cyto-
plasm when alkaline phosphatase pretreated extracts were
added (Fig. 5 e). These results indicate that the S100C in
normal cells is phosphorylated specifically at the confluent
stage, forms a complex with unidentified protein(s) (Fig. 5
d, large band), and moves into the nucleus.
Physiological Significance of Phosphorylation of 
Threonine 10 in S100C
We attempted to determine which amino acid(s) of S100C
in normal fibroblasts were phosphorylated in response to
high cell density. Furthermore, in order to determine
whether endogenous and recombinant S100Cs were phos-
phorylated at the same or at distinct site(s), we performed
2-D separation of lysylic fragments of immunoprecipitated
32P-labeled endogenous S100C and 32P-labeled recombi-
nant S100C. As shown in Fig. 6 a, only one peptide derived
from endogenous S100C was phosphorylated (Fig. 6 a, left
panel, NC1), and the same was true of recombinant S100C
(Fig. 6 a, right panel, NR1). Locations of phosphopeptide
spots NC1 and NR1 were completely consistent, indicating
that endogenous and recombinant S100Cs are phosphory-
lated at the same site. To identify the phosphopeptide, we
performed NH2-terminal sequence analysis of the peptide.
As a result, both the sequences of phosphopeptides (NC1
and NR1) were ISSPTETERCIESLIAVFQK (data not
shown). Phosphoamino acid analysis of 32P-labeled S100C
Figure 5. Phosphorylation
and nuclear accumulation of
S100C. (a) Confluent normal
(panels I and II) and immor-
talized cells (panels III and
IV) were permeabilized by
treatment with digitonin.
These permeabilized cells
were incubated with extracts
of immortalized (panels I and
II) or normal cells (panels III
and IV). The extracts were
prepared from semiconfluent
(panels I and III) and conflu-
ent cultures (panels II and
IV). S100C in the permeabi-
lized cells treated with vari-
ous cell extracts was visual-
ized with rabbit anti-S100C
antibody as the primary anti-
body and FITC-conjugated
goat anti–rabbit IgG antibody
as the secondary antibody.
Immortalized cell extracts
had no effect on localization
of S100C in normal confluent
cells (panels I and II). Ex-
tracts of normal confluent
cells caused nuclear transition
of S100C in the immortalized
cells at confluence (panel
IV), but normal semiconflu-
ent cell extracts had no effect
(panel III). Bar, 20 mm. (b)
Cells were incubated with
[32P]orthophosphate, and sol-
uble (S) and nuclear (N) frac-
tions of the cells were then
immunoprecipitated with rab-
bit anti-S100C antibody. Im-
munoprecipitates were sepa-
rated on 15% tricine SDS-PAGE and transferred to nitrocellulose membranes. Phosphorylated S100C was detected by
autoradiography (upper). Immunoprecipitated S100C was detected by Western blotting (lower). (c) Whole cell lysates from normal
confluent cells were treated with (1) or not treated with (2) alkaline phosphatase (APP). Phosphorylation of S100C in whole cell ly-
sates was markedly reduced by treatment of the lysates with APP (upper). Immunoprecipitated S100C was detected by Western blot-
ting (lower). (d) Native PAGE Western blot analysis of S100C protein complex in whole cell lysates from normal and immortalized cells
at semiconfluent and confluent stages. The cell lysates treated with (1) or not treated with (2) APP were subjected to 4% native
PAGE and immunoblotted with rabbit anti-S100C antibody. (e) Normal confluent cell extracts were treated with (panel II) or not
treated with APP (panel I). APP-treated extracts did not cause nuclear transition of S100C in the permeabilized-immortalized cells at
confluence (panel II). Bar, 20 mm.Sakaguchi et al. S100C and Cell Growth 1201
showed that threonine was phosphorylated in endogenous
S100C (Fig. 6 b, left). When recombinant S100C was incu-
bated with confluent normal cell lysates, threonine resi-
dues were also phosphorylated (Fig. 6 b, right). These re-
sults indicate that S100C is phosphorylated on threonine
residue(s) of the NH2-terminal 20–amino acid fragment
ISSPTETERCIESLIAVFQK (I4-K23 region) in vivo and
in vitro.
Figure 6. Necessity of phos-
phorylation of S100C on
threonine 10 for nuclear im-
port. (a) Comparative pep-
tide mapping of phosphory-
lated S100C. In vivo (left
panel) and in vitro (right
panel) phosphorylations of
S100C (endogenous and re-
combinant S100Cs) were per-
formed as described in Mate-
rials and Methods. Peptides
from lysyl endopeptidase-
treated  32P-labeled endo-
genous S100C (left panel)
or  32P-labeled recombinant
S100C (right panel) were pre-
pared and were separated by
electrophoresis and ascend-
ing chromatography. Each
spot named NC1 (in vivo
condition, left panel) and
NR1 (in vitro condition, right
panel) was detected for en-
dogenous or recombinant
phosphorylated S100C, re-
spectively. Peptide sequences
of both NC1 and NR1
were completely identical,
i.e., ISSPTETERCIESLIAV-
FQK. This peptide indicates
the phosphorylation site of
S100C in normal cells in re-
sponse to high cell density.
(b) Phosphoamino acid anal-
ysis of S100C. Phosphoamino
acid analysis of 32P-labeled
S100C was performed by the
acid hydrolysis method. 32P-
labeled phosphothreonine
was detected in both in vivo
(left) and in vitro (right) con-
ditions after exposure for 1
wk. Samples were spotted
at the bottom of thin
layer plates. The mobilities
of phosphotyrosine (P-Y),
phosphothreonine (P-T), and
phosphoserine (P-S) standards are indicated at the left vertical axis. Threonine was the amino acid phosphorylated in S100C. (c) Phos-
phorylation and nuclear accumulation of S100C. Various purified recombinant S100C homologues (wild-type S100C, 8-10 A/T S100C, 8
A/T S100C, and 10 A/T S100C) were labeled with a fluorescent probe as described in Materials and Methods. In vitro phosphorylation
reactions of these labeled homologues were performed (upper panel). These 32P-labeled recombinant S100C homologues were sub-
jected to SDS-PAGE and detected by autoradiography (upper panel, top) or CBB staining (upper panel, bottom). Wild-type S100C
(lane 1) and 8 A/T S100C (lane 3) were strongly phosphorylated by coincubation with confluent normal cell homogenates, but 8-10 A/T
S100C (lane 2) and 10 A/T S100C (lane 4) were not phosphorylated under the same conditions. Confluent HeLa cells permeabilized
with digitonin (lower panel, 1–4 and 19–49) were incubated with various reaction mixtures (upper panel, lanes 1–4). Exogenously added
fluorescent S100C homologues in the permeabilized cells were visualized under a fluorescent microscope (lower panel, 1–4). Nuclei of
the permeabilized cells were stained with Hoechst 33258 (lower panel, 19–49). Treatment with extracts of confluent normal cells caused
nuclear transition of the wild-type S100C (lower panel, 1 and 19) and the 8 A/T S100C (bottom panel, 3 and 39) in the permeabilized
cells, but the nonphosphorylation type 8-10 A/T (lower panel, 2 and 29) and 10 A/T S100C (lower panel, 4 and 49) were not imported
into the nuclei. Bars, 20 mm.The Journal of Cell Biology, Volume 149, 2000 1202
Our findings raise the possibility that the phosphoryla-
tion site may be important for nuclear import of S100C. To
test whether this phosphorylation regulates nuclear local-
ization of S100C, we produced three recombinant S100C
protein homologues lacking the phosphorylation sites of
the I4-K23 region. The threonines 8 (T8; bold italics) and
10 (T10; bold italics) were changed to alanine (8-10 A/T
S100C), and T8 alone (8 A/T S100C) or T10 alone (10 A/T
S100C) was changed to alanine. As shown at the top of
Fig. 6 c, we found that wild-type S100C and mutant-type 8
A/T, but not 8-10 A/T S100C or 10 A/T S100C, were phos-
phorylated by incubation with confluent normal cell ly-
sates. Thus, T10 was the primary site of phosphorylation
in normal cells at high cell density.
We further investigated nuclear movement of exoge-
nous recombinant S100C homologues that were added to
the confluent permeabilized HeLa cells. Unlike the wild-
type protein, the mutants (8-10 A/T S100C and 10 A/T
S100C) showed almost entirely extranuclear localization
(Fig. 6 c, lower panel). The mutant 8 A/T S100C was local-
ized in the nuclei (Fig. 6 c, lower panel). Thus, we found
that the phosphorylation on a T10 is necessary to direct
S100C to the nucleus.
To determine whether endogenous S100C can move
from the cytoplasm into the nucleus under normal physio-
logical conditions, we microinjected rabbit anti-S100C an-
tibody or anti-albumin antibody (a non–cross-reactive IgG
against S100C) directly into the cytoplasm of living normal
cells at confluence. Consequently, rabbit anti-S100C anti-
body entered the nuclei of the injected cells at a frequency
of 85% (Fig. 7, a-1 and a-2), whereas anti-albumin anti-
body injected into the cytoplasm did not (Fig. 7, c-1 and c-2).
These results indicate that the nuclear envelope was intact
and that the rabbit anti-S100C antibody bound to S100C
moved into the nucleus from the cytoplasm. Contrarily,
when the rabbit anti-S100C antibody was injected into the
cytoplasm of immortalized cells at confluence, the anti-
body remained in the cytoplasm (Fig. 7, b-1 and b-2). It is
well known that the antibody cannot go through nuclear
pores due to its large size. Therefore, the present results
Figure 7. Effect of rabbit anti-S100C antibody on DNA synthesis in normal quiescent cells at confluence. (a–c) Rabbit anti-S100C (a
and b) and anti-albumin (c) antibodies were injected into the cytoplasm of normal (a and c) and immortalized cells (b) at confluence.
Localization of rabbit anti-S100C antibody in the injected cells was detected with FITC-conjugated goat anti–rabbit IgG antibody (a-1,
b-1, and c-1, green). Nuclei were stained with Hoechst 33258 (a-2, b-2, and c-2, blue). (d) Rabbit anti-S100C antibody was microinjected
into the cytoplasm of normal quiescent cells at confluence (d-1, d-2, and d-3). Localization of rabbit anti-S100C antibody in the injected
cells was visualized in the nuclei (arrows) and the cytoplasm (arrowheads) with TRITC-conjugated goat anti–rabbit IgG antibody (d-1,
red). 24 h after injection, DNA synthesis was assessed by immunofluorescence staining with mouse anti-BrdU antibody (d-2, green, ar-
rows). Nuclei were stained with Hoechst 33258 (d-3, blue). Bars, 20 mm.Sakaguchi et al. S100C and Cell Growth 1203
suggest that S100C in living normal cells at confluence can
move from the cytoplasm into the nucleus but that S100C
in immortalized cells cannot.
Involvement of Nuclear S100C in the Cell
Growth Arrest
Anti-S100C antibody was microinjected into the cytoplasm
of normal quiescent cells at confluence to determine the
biological significance of nuclear accumulation of S100C.
Only when the injected anti-S100C antibody formed a
complex with S100C protein and moved into nuclei (Fig. 7,
d-1 and d-3, arrows) did the cells incorporate BrdU into
their nuclei (Fig. 7, d-2 and d-3, arrows). On the other
hand, cytoplasmic injection of anti-albumin antibody or
IgG fraction prepared from preimmune serum showed no
movement of the antibody into their nuclei and did not in-
duce the incorporation of BrdU (data not shown). Since
blocking the intranuclear S100C functions with anti-S100C
antibody that entered the nucleus caused DNA synthesis
in quiescent cells, nuclear accumulation of S100C may be
closely related to inhibition of DNA synthesis in normal
human fibroblasts at confluence.
To further evaluate the association of nuclear S100C
with the cell growth arrest, we employed a Tet-on/off gene
expression system. Since the endogenous S100C in Tet-off
HeLa cells was localized only in the cytoplasm, the exo-
genous S100C may also be localized in the cytoplasm. An
NLS was linked to S100C by a PCR technique to compel
exogenous S100C to move into the nucleus. Tet-off HeLa
cells were transfected with an empty vector, pTRE (Fig. 8
a, panels I and II and Fig. 8 b, panels I and II), or an ex-
Figure 8. Association of nu-
clear S100C with cell growth
arrest. Localization of S100C
(a) and incorporation of
BrdU (b) in Tet-off HeLa
cells transfected with pTRE
S100C-NLS were assessed by
immunofluorescence stain-
ing. Semiconfluent Tet-off
HeLa cells transfected with
the empty vector alone (a,
panels I and II; b, I and II),
with pTRE S100C (a, panels
III and IV; b, panels III and
IV), and with pTRE S100C-
NLS (a, panels V and VI; b,
panels V and VI) were
stained for S100C or BrdU
under tetracycline-plus (a,
panels I, III, and V, green; b,
panels I, III, and V, left, red)
and -minus (a, panels II, IV,
and VI, green; b, panels II,
IV, and VI, left, red) condi-
tions. When tetracycline was
removed from the medium,
S100C was detected in the
nuclei of Tet-off HeLa cells
transfected with pTRE
S100C-NLS (a, panel VI,
green), and their BrdU incor-
poration was remarkably de-
creased (b, panel VI, red).
Nuclei were simultaneously
stained with Hoechst 33258
(b, panels I–VI, right, blue).
Bars, 20 mm. (c) Tritiated
thymidine incorporation by
Tet-off HeLa cells trans-
fected with pTRE S100C-
NLS was assessed under tetracycline-plus and -minus conditions. After deprivation of tetracycline in the medium, DNA synthesis de-
creased in a time-dependent manner. (d) 6 h after deprivation of tetracycline from the culture medium, transfected cells were further
incubated with [32P]orthophosphate for 6 h, and the cells were then immunoprecpitated with rabbit anti-S100C antibody. Phosphory-
lated S100C was detected by autoradiography (upper). Immunoprecipitated S100C was detected by Western blotting (lower). Phos-
phorylation of S100C in these cells was not observed. (e) Under the condition of deprivation of tetracycline in the culture medium, the
expressions of three cyclin-dependent kinase inhibitors, p21Waf1, p27Kip1, and p16Ink4a, were analyzed in semiconfluent Tet-off HeLa cells
transfected with the pTRE empty vector (left), and the pTRE S100C (middle) and pTRE S100C-NLS expression vectors (right) by
Western blotting. (Lanes 1–4) 0, 3, 6, and 12 h after deprivation of tetracycline, respectively.The Journal of Cell Biology, Volume 149, 2000 1204
pression vector of wild-type S100C, pTRE S100C (Fig. 8 a,
panels III and IV and Fig. 8 b, panels III and IV), or an
expression vector of S100C-NLS fusion protein, pTRE
S100C-NLS (Fig. 8 a, panels V and VI and Fig. 8 b, panels
V and VI). Clones overexpressing wild-type S100C or
S100C-NLS under a tetracycline-free condition were iso-
lated and analyzed. The expression levels of S100C or
S100C-NLS proteins in the clones, Tet-off HeLa/pTRE
S100C, and Tet-off HeLa/pTRE S100C-NLS, were seven
and ten times higher than the basal level in the control
Tet-off HeLa/pTRE clone, respectively (Fig. 8 d, lower).
Immunocytochemical studies revealed that when tetracy-
cline was deprived from the medium (Fig. 8 a, panels II,
IV, and VI and Fig. 8 b, II, IV, and VI), exogenous S100C-
NLS protein expressed in the transfected cells efficiently
moved to and accumulated in the nuclei (Fig. 8 a, panel
VI). However, the overexpressed wild-type S100C did not
move into the nuclei (Fig. 8 a, panel IV). Although neither
S100C nor S100C-NLS was phosphorylated (Fig. 8 d, up-
per), the latter protein could move into the nuclei because
of the presence of NLS. Interestingly, the S100C-NLS–
overexpressing cells displayed more flattened morphology
(Fig. 8 a, panel VI) as compared with the cells under the
tetracycline-plus condition (Fig. 8 a, panel V) and their
mother cells (Fig. 8 a, panels I and II). On the other hand,
the wild-type S100C-overexpressing cells showed polygo-
nal morphology with some protrusions (Fig. 8 a, panel IV).
Then, DNA synthesis was assessed in the Tet-off HeLa/
pTRE S100C-NLS clone by incorporation of BrdU or
[3H]thymidine. BrdU staining revealed that DNA synthe-
sis was inhibited by nuclear accumulation of the fusion
protein (Fig. 8 b, panel VI), whereas the wild-type S100C-
expressing cells continued to synthesize DNA under the
deprivation of tetracycline in the culture medium (Fig. 8 b,
panel IV). This inhibition was time-dependent after depri-
vation of tetracycline in the culture medium, and the max-
imum inhibition was z50% at 12 h (Fig. 8 c).
Expression of cyclin-dependent kinase inhibitors such as
p21Waf1 and p16Ink4a was tested in the Tet-off HeLa/pTRE
S100C-NLS clone. As shown in Fig. 8 e, both p21Waf1 and
p16Ink4a were remarkably induced as early as 3 h after the
deprivation of tetracycline in parallel with the expression
of exogenous S100C-NLS, whereas p27Kip1 level did not
change. The overexpression of exogenous wild-type S100C
had no effect on the expression of p21Waf1 and p16Ink4a.
Discussion
Association of Cytoplasmic S100C with the Regulation 
of Actin Organization and Its Dynamics
In this study, we found that S100C was remarkably down-
regulated in immortalized cells at low cell density as com-
pared with their normal counterparts, and that S100C was
directly associated with actin filaments in the cytoplasm in
normal and immortalized cells. Furthermore, we observed
that high expression of exogenous S100C caused drastic
changes in the morphology of immortalized cells at low
cell density. This morphological change was associated
with the formation of cell protrusions with densely orga-
nized actin filaments. Thus, it is likely that cytoplasmic
S100C is implicated in the regulation of actin organization
and actin filament dynamics. Intracytoplasmic injection of
anti-S100C antibody caused multinucleation in most of the
injected normal fibroblasts at low cell density (data not
shown). In addition, multinucleated cells were often ob-
served in cultures of immortalized cells at low cell density.
Thus, formation of the S100C immunocomplex may lead
to the abnormal formation of actin contractile ring in cy-
tokinesis (Haraguchi et al., 1997).
Nuclear Accumulation of S100C and Cell
Density–dependent Growth Arrest
Normal human fibroblasts go into the stage of growth ar-
rest at confluence. However, little is known about the mo-
lecular mechanism underlying this phenomenon. As a clue
to resolve this matter, it is important to understand how
the information of growth arrest is transported from the
cell–cell contact sites into the nucleus, where the on/off
switch of several gene expression systems related to
growth arrest are present. In other words, sites of cell–cell
contact regions may represent signaling hotspots on the
cell surface.
S100C was phosphorylated in normal human fibroblasts
at high cell density. Interestingly, S100C was released from
actin filaments when S100C was specifically phosphory-
lated on threonine 10. In other words, the binding abil-
ity of S100C to actin filaments was extremely diminished
by the phosphorylation even in the presence of a high
concentration of Ca21 (data not shown). Phosphorylated
S100C was accumulated in the nuclei of normal human fi-
broblasts. This result may be reasonable for the nuclear
import mechanism of S100C because it may be impossible
for S100C to move into the nucleus if the protein remains
to be linked to actin filaments in the cytoplasm. Thus, dis-
sociation of S100C from actin filaments may be one factor
involved in the nuclear import mechanism of the protein.
In immortalized cells, S100C was neither phosphory-
lated nor imported to the nucleus. Thus, phosphorylation
of S100C on threonine 10 may be essential to import into
the nucleus through interaction with putative S100C-bind-
ing protein(s) containing an NLS (Dingwall and Laskey,
1991) and to contribution to the cell density–dependent
growth arrest. In fact, when the phosphorylated S100C
in normal cell lysates from confluent culture was de-
phosphorylated by treatment of the lysates with alkaline
phosphatase, the nuclear import of S100C was markedly
diminished. Furthermore, recombinant S100C protein ho-
mologues lacking the phosphorylation site never localized
in the nucleus. Thus, we emphasize that the phosphoryla-
tion on threonine 10 is necessary for the cytoplasmic
S100C to move to the nucleus. Since we did not find the
NLS sequence in S100C by examining the amino acid se-
quence of this protein, we suppose that phosphorylated
S100C could be associated with an unknown NLS-bearing
protein and then their complex could move into the nu-
cleus through interaction with nuclear transporters, such
as importin-a (Gorlich et al., 1994; Moroianu et al., 1995;
Weis et al., 1995) and importin-b (Chi et al., 1995; Radu et al.,
1995; Cingolani et al., 1999).
Nuclear accumulation of S100C seems to be closely re-
lated to cell density–dependent growth arrest in cultures
of normal human fibroblasts. The neoplastic cells such asSakaguchi et al. S100C and Cell Growth 1205
HeLa, KMST-6/Ras, and Saos-2 cells show no contact in-
hibition of growth. Therefore, we hypothesized that nu-
clear import of S100C could not occur in neoplastic cells.
In fact, we found that S100C was localized only in the cyto-
plasm of neoplastic HeLa, KMST-6/Ras, and Saos-2 cells,
and that the phosphorylation of S100C in these cells did
not occur even after confluence (data not shown). Thus,
disorder of the nuclear import mechanisms of S100C may
impair cell density–dependent growth arrest in immortal-
ized and neoplastic cells at confluence.
To clarify the relationship between nuclear accumula-
tion of S100C and cell growth arrest, we transfected Tet-
off HeLa cells with a plasmid pTRE S100C-NLS. Under
deprivation of tetracycline in the culture medium, the
transfected cells stably expressed significant amount of
S100C-NLS fusion protein which was not phosphorylated
but accumulated in the nuclei of the transfected Tet-off
HeLa cells. By this approach, it became clear that accumu-
lation of S100C-NLS in the nuclei of HeLa cells signifi-
cantly inhibited DNA synthesis of the cells. Interestingly,
expression of both p21Waf1 and p16Ink4a, the well known in-
hibitors of cyclin-dependent kinases (Hunter, 1993; Ser-
rano et al., 1993), was increased in parallel with the nu-
clear accumulation of S100C. These results indicate that
p21Waf1 and p16Ink4a may mediate downregulation of DNA
synthesis by the nuclear S100C. Thus, whenever cytoplas-
mic S100C is artificially compelled to move into the nu-
cleus, S100C can act as a mediator of the cell-cycle arrest
independently of its phosphorylation or nonphosphoryla-
tion conditions. However, naturally, when the phosphory-
lation of S100C does not occur in the cytoplasm, S100C
can neither move into the nucleus nor act as a cell-cycle
downregulator. Consequently, we conclude that the phos-
phorylation of S100C is necessary for the nuclear import
and the following suppression of DNA synthesis in cells.
It is clear that S100C shuttles between the cytoplasm
and the nucleus of normal human fibroblasts in a cell den-
sity–dependent fashion. Recent studies also have demon-
strated that the same proteins reside both at adherent
junctions and in the nucleus. For example, the tight junc-
tion protein ZO-1 accumulates in the nucleus in a cell den-
sity–dependent fashion (Gottardi et al., 1996), and the fo-
cal contact protein Zyxin shuttles between the nucleus and
the sites of cell adhesion in fibroblasts (Nix and Beckerle,
1997).
b-Catenin, a protein present at cell–cell adherent junc-
tions, has been shown to work as a DNA-binding tran-
scriptional regulator when b-catenin–Lef-1 transcription
factor complex accumulates in the nucleus (Gumbiner,
1995; Behrens et al., 1996; Huber et al., 1996; Orsulic and
Peifer, 1996). Recently, Carrión et al. (1999) have re-
ported that DREAM (downstream regulatory element
[DRE]-antagonist modulator), an EF-hand type Ca21-
binding protein, binds to the DRE sequence and acts as a
location-dependent gene silencer of the human prodynor-
phin gene. Thus, the structure of the EF-hand helix-loop-
helix motif domain appears to be compatible with a nu-
cleic acid–binding function. In fact, we found that both
cellular S100C and recombinant S100C protein bound to
double-stranded DNA coupled with a cellulose column
(data not shown). Like DREAM, the EF-hand type Ca21-
binding protein S100C may also work as a DNA-bind-
ing transcriptional regulator for cell density–dependent
growth arrest.
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